Article Text

Download PDFPDF
▼Xiapex for Dupuytren's contracture
  • Relevant BNF section: BNF 10.3.1

Abstract

Dupuytren's contracture is a benign, progressive disabling condition of the hands.12 Traditionally, surgery (e.g. fasciotomy, fasciectomy, joint fusion and amputation) has been the only effective treatment but it is not an option for every patient.34 A potential alternative intervention is a formulation of collagenase Clostridium histolyticum (▼Xiapex - Pfizer Limited), which has been licensed for injection directly into the affected joint as treatment for adults with Dupuytren's contracture.5 Here we review the evidence for collagenase C. histolyticum and discuss its place in the management of this condition.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

  • Relevant BNF section: BNF 10.3.1

View Full Text

Footnotes